<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02721368</url>
  </required_header>
  <id_info>
    <org_study_id>MT_PRT_MVD01</org_study_id>
    <nct_id>NCT02721368</nct_id>
  </id_info>
  <brief_title>Neuramis® Volume Lidocaine Treatment in Patients With Loss of Mid-face Volume</brief_title>
  <official_title>Clinical Study of Neuramis® Volume Lidocaine to Evaluate the Efficacy and Safety for Temporary Restoring the Mid-face Volume</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medy-Tox</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medy-Tox</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the safety and efficacy of Neuramis® Volume
      Lidocaine, which is a biomaterial prosthesis and graft, with Juvederm® Voluma® with
      Lidocaine, for the patients who need correction due to a moderate-to-severe volume loss in
      the mid-facial region by inducing temporary volume restoration in mid-facial region.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-centered, randomized, double-blind, split-face clinical study on
      investigational device. The subjects in this clinical trial receive application of the
      investigational device on the right and left side of the mid-facial region (Neuramis® Volume
      Lidocaine or Juvederm® Voluma® with Lidocaine).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 3, 2016</start_date>
  <completion_date type="Actual">May 2, 2018</completion_date>
  <primary_completion_date type="Actual">October 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ratio of subjects defined as improved by independent photograph evaluator according to the overall MFVDS</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Investigational medical device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Neuramis® Volume Lidocaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator medical device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Juvederm® Voluma® with Lidocaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neuramis® Volume Lidocaine</intervention_name>
    <description>hyaluronic acid filler</description>
    <arm_group_label>Investigational medical device</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Juvederm® Voluma® with Lidocaine</intervention_name>
    <description>hyaluronic acid filler</description>
    <arm_group_label>Comparator medical device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject aged between 35 and 65.

          2. Mid-facial region symmetrial, severity greater than MFVDS moderate-to-severe level

        Exclusion Criteria:

          1. Those who have anticoagulant therapy, antiplatelet therapy, and non-steroidal
             anti-inflammatory drugs

          2. Those who have history of receiving the procedures which are considered to affect on
             the assessment of this clinical trial.

          3. Those who has thin skin in the mid-facial area

          4. Those with hypersensitivity to sodium hyaluronate or lidocaine or amide type local
             anesthetics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>BeomJoon Kim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chung-Ang Univ. Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chung-Ang Univ. Medical Center</name>
      <address>
        <city>Seoul</city>
        <state>Dongjak-gu</state>
        <zip>156-755</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>March 14, 2016</study_first_submitted>
  <study_first_submitted_qc>March 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2016</study_first_posted>
  <last_update_submitted>January 15, 2019</last_update_submitted>
  <last_update_submitted_qc>January 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

